RILP Gene

RILP Gene

Introduction

Rilp Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@cantalupo2001]
<div class="infobox-header">RILP</div> [@jordens2001]
<div class="infobox-content"> [@mcgough2017]
<table> [@xiong2012]
<tr><th>Full Name</th><td>RILP (Rab Interacting Lysosomal Protein)</td></tr> [@gan2011]
<tr><th>Chromosome</th><td>chr17</td></tr> [@cheng2020]
<tr><th>Location</th><td>17p13.2</td></tr> [@hu2019]
<tr><th>NCBI Gene ID</th><td>[83596](https://www.ncbi.nlm.nih.gov/gene/83596)</td></tr>
<tr><th>OMIM</th><td>[607823](https://www.omim.org/entry/607823)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000131845](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131845)</td></tr>
<tr><th>UniProt</th><td>[Q8IVF2](https://www.uniprot.org/uniprotkb/Q8IVF2/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Lysosomal Storage Disorders, Neurodegeneration</td></tr>
<tr><th>Protein Class</th><td>Rab Effector, Autophagy Adapter</td></tr>
<tr><th>Expression</th><td>Ubiquitous, high in brain</td></tr>
</table>
</div>
</div>

Overview

RILP Gene

Introduction

Rilp Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@cantalupo2001]
<div class="infobox-header">RILP</div> [@jordens2001]
<div class="infobox-content"> [@mcgough2017]
<table> [@xiong2012]
<tr><th>Full Name</th><td>RILP (Rab Interacting Lysosomal Protein)</td></tr> [@gan2011]
<tr><th>Chromosome</th><td>chr17</td></tr> [@cheng2020]
<tr><th>Location</th><td>17p13.2</td></tr> [@hu2019]
<tr><th>NCBI Gene ID</th><td>[83596](https://www.ncbi.nlm.nih.gov/gene/83596)</td></tr>
<tr><th>OMIM</th><td>[607823](https://www.omim.org/entry/607823)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000131845](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131845)</td></tr>
<tr><th>UniProt</th><td>[Q8IVF2](https://www.uniprot.org/uniprotkb/Q8IVF2/entry)</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Lysosomal Storage Disorders, Neurodegeneration</td></tr>
<tr><th>Protein Class</th><td>Rab Effector, Autophagy Adapter</td></tr>
<tr><th>Expression</th><td>Ubiquitous, high in brain</td></tr>
</table>
</div>
</div>

Overview

RILP (Rab Interacting Lysosomal Protein) is a key effector protein that regulates lysosomal trafficking, autophagosome-lysosome fusion, and endolysosomal dynamics. RILP serves as a critical link between Rab GTPases and the autophagy-lysosomal pathway, making it a significant player in neurodegenerative diseases characterized by protein aggregate accumulation. The protein interacts with Rab7 (RAB7) to coordinate late endosomal and lysosomal transport, and with the dynein-dynactin motor complex to facilitate retrograde movement of lysosomes along microtubules.

Gene Structure

The RILP gene is located on chromosome 17p13.2 and consists of 14 exons spanning approximately 12 kb. The gene encodes a protein of 710 amino acids with a molecular weight of approximately 77 kDa. Alternative splicing produces multiple transcript variants with tissue-specific expression patterns. The RILP promoter contains response elements for various transcription factors including [NF-κB](/entities/nf-kb), making its expression responsive to inflammatory signals.

Protein Structure and Domains

RILP contains several functional domains:

• N-terminal Domain: Contains the Rab7-binding region (RBD) that recognizes active GTP-bound Rab7
• Central Coiled-Coil Region: Mediates homodimerization and interaction with other proteins
• C-terminal Domain: Contains the dynein-dynactin binding motif
• Phosphorylation Sites: Multiple serine/threonine residues regulated by kinases including LRRK2

Normal Function

Lysosomal Trafficking

• Recruits active Rab7 to lysosomal membranes
• Coordinates tethering and fusion events
• Regulates lysosomal size and distribution
• Controls cargo delivery to lysosomes

Autophagosome-Lysosome Fusion

• Facilitates recruitment of autophagosomes to lysosomes
• Promotes SNARE-mediated membrane fusion
• Regulates the maturation of autophagosomes to autolysosomes
• Essential for bulk degradation of protein aggregates and damaged organelles

Retrograde Transport

• Enables minus-end-directed transport along microtubules
• Facilitates perinuclear clustering of lysosomes
• Important for neuronal lysosomal positioning
• Regulates synaptic vesicle recycling

Innate Immunity

• Regulates phagosome maturation
• Controls antigen presentation
• Modulates inflammatory responses

Disease Associations

Parkinson's Disease

• LRRK2 Interaction: RILP directly interacts with LRRK2 (leucine-rich repeat kinase 2), a major PD-causing gene. Pathogenic LRRK2 mutations disrupt RILP-mediated lysosomal trafficking.
• [Autophagy](/entities/autophagy) Dysregulation: Impaired RILP function leads to defective clearance of [α-synuclein](/proteins/alpha-synuclein) aggregates, a hallmark of PD.
• Dopaminergic Neuron Vulnerability: RILP dysfunction specifically affects dopaminergic [neurons](/entities/neurons) in the substantia nigra, which rely heavily on autophagy for survival.
• Genetic Associations: RILP variants have been associated with sporadic PD risk in genome-wide studies.

Lysosomal Storage Disorders

• Impaired trafficking of lysosomal enzymes
• Accumulation of undegraded material
• Secondary neurodegeneration

Alzheimer's Disease

• RILP regulates [amyloid precursor protein](/entities/app-protein) (APP) processing
• Lysosomal dysfunction contributes to amyloid plaque formation
• Impaired autophagic flux in AD brains involves RILP dysregulation

Amyotrophic Lateral Sclerosis (ALS)

• RILP-mediated transport defects in motor neurons
• Impaired clearance of protein aggregates
• Interaction with ALS-associated proteins

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin-protein) impairs RILP function
• Contributes to defective autophagy
• Aggravates aggregate accumulation

Expression Pattern

RILP exhibits widespread expression:

• High Expression: Substantia nigra (dopaminergic neurons), [hippocampus](/brain-regions/hippocampus) (CA1 pyramidal cells), [cortex](/brain-regions/cortex) (pyramidal neurons), cerebellar Purkinje cells
• Moderate Expression: Striatum, thalamus, hypothalamus
• Peripheral Tissues: Liver, kidney, pancreas, immune cells

Molecular Mechanisms

Rab7 Interaction

• Rab7-RILP complex formation is GTP-dependent
• Multiple RILP molecules can bind per Rab7 dimer
• Interaction is regulated by GAPs and GEFs

Dynein-Dynactin Recruitment

• The C-terminal domain contains the dynein-binding motif
• This enables minus-end-directed transport
• Regulated by phosphorylation

LRRK2 Phosphorylation

• Phosphorylation modulates RILP localization
• Pathogenic LRRK2 mutations cause hyperphosphorylation
• Disrupts lysosomal trafficking

Autophagy Regulation

• Initiation: Recruiting isolation membranes
• Elongation: Facilitating ATG protein recruitment
• Fusion: Promoting SNARE complex assembly
• Degradation: Enabling lysosomal enzyme access

Therapeutic Implications

Small Molecule Modulators

• Lysosomal enhancers: Promote RILP function
• Autophagy inducers: Rapamycin, metformin enhance clearance
• LRRK2 inhibitors: Prevent aberrant RILP phosphorylation

Gene Therapy Approaches

• AAV-RILP overexpression to enhance lysosomal function
• CRISPR correction of RILP mutations
• siRNA to reduce toxic gain-of-function

Repurposed Drugs

• Lithium: Enhances autophagy via RILP
• Carbamazepine: Induces autophagy
• Trehalose: RILP-dependent autophagic enhancement

Combination Strategies

• RILP modulation + α-synuclein immunotherapy
• LRRK2 inhibitors + autophagy enhancers
• Neurotrophic factors + lysosomal enhancement

Animal Models

Knockout Mice

• RILP KO: Embryonic lethal (most die in utero)
• Conditional KO in neurons: Neurodegeneration, accumulation of autophagic vacuoles
• Impaired lysosomal function in dopaminergic neurons

Transgenic Models

• Overexpression: Enhanced lysosomal activity
• PD-linked mutations: Model α-synuclein pathology
• Reporter lines: Fluorescent RILP for visualization

Zebrafish Models

• Morpholino knockdown: Developmental defects
• Relevance to neurodevelopment

Research Directions

• Developing brain-penetrant RILP modulators
• Understanding RILP in α-synuclein clearance
• Biomarker development for RILP-targeted therapies
• Clinical translation of preclinical findings

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
• [RILP Protein](/proteins/rilp-protein)
• [Autophagy Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [LRRK2 Gene](/proteins/lrrk2-protein)

External Links

• [NCBI Gene: RILP](https://www.ncbi.nlm.nih.gov/gene/83596)
• [UniProt: RILP](https://www.uniprot.org/uniprotkb/Q8IVF2/entry)
• [Ensembl: RILP](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000131845)
• [OMIM: RILP](https://www.omim.org/entry/607823)

Background

The study of Rilp Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving RILP Gene discovered through SciDEX knowledge graph analysis: